Gilead to buy Immunomedics in $21B deal


Gilead to buy Immunomedics in $21B deal






Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the companies said on Sunday in a statement.



via FOX BUSINESS NEWS https://ift.tt/32nOYMu Markets

About Real business info


There are so many different possibilities to start an online business with real business info, We will guide you to choose the best business for you and earn as much money as possible

don't forget to subscribe to get us latest business news

Post a Comment

0 Comments